Autocyte PREP

Autocyte PREP®

A monolayer slide preparation and discrete-staining lab product used for cytologic specimens (e.g., Pap smears).

Autocyte PREP®

Cytology A monolayer slide preparation and discrete-staining lab product used for cytologic specimens–eg, Pap smears. See Pap smear.
References in periodicals archive ?
Direct-to-vial experience with Autocyte PREP in a small New England regional cytology practice.
Dual sampling of the endocervix and its impact on AutoCyte Prep endocervical adequacy.
Earlier this year he relinquished his European export director's role with CellPath to concentrate on developing the company's sales of the AutoCyte PREP liquid based cytology system in the UK and Ireland for United States manufacturers TriPath Imaging.
The company produces the AutoCyte PREP system, which aims to speed the process of analysing smear tests Mrs Betts, 37, aims to put six years of experience as a cytoscreener at Llandough Hospital to good use.
* For most women, there is no reason to replace conventional Papanicolaou (Pap) tests with FBC Pap tests (such as ThinPrep Pap Test and AutoCyte PREP System).
Direct-to-vial use of the AutoCyte PREP liquid-based preparation for cervical-vaginal specimens in three European laboratories.
* TriPath Imaging Inc., Burlington, NC, has received FDA approval to include the screening of AutoCyte Prep thin-layer slide preparations on the AutoPap Primary Screening System.
TriPath says the system identifies up to 25 percent of conventional and AutoCyte Prep slides that receive AutoPap review only and might be archived as normal.
Managing director Terry Hammett will run CellPath's sales team, while Adrian Jackson relinquishes his European export director's role to concentrate on developing sales of the company's AutoCyte PREP liquid-based cytology system in the UK and Republic of Ireland.
recently announced that the FDA has approved the PREPmate, an accessory to the AutoCyte [R] PREP System and the manual method for preparation of AutoCyte Prep thin-layer slides for cytologic screening for uterine cervical cancer.
A similar study reported in the Journal of Reproductive Medicine (45:1-16) showed a 157% increase in HSIL detection over traditional methods using the company's AutoCyte PREP method, which is performed on the AutoPap system.